Chengdu Easton Biopharmaceuticals Co., Ltd. (SHA:688513)
China flag China · Delayed Price · Currency is CNY
64.02
-0.66 (-1.02%)
May 12, 2026, 3:00 PM CST

SHA:688513 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
326.01855.43971.4781.23830.971,051
Trading Asset Securities
1,296758452.35741.78516.36453.84
Cash & Short-Term Investments
1,6221,6131,4241,5231,3471,505
Cash Growth
8.61%13.32%-6.52%13.04%-10.45%-7.43%
Accounts Receivable
213.47257.78288.44177.7180.92126.73
Other Receivables
0.440.310.440.661.250.17
Receivables
213.91258.09288.88178.36182.17126.9
Inventory
246.66228.71190.09160.98140.87103.68
Prepaid Expenses
--4.224.112.783.2
Other Current Assets
35.2831.9321.7616.4125.9740.76
Total Current Assets
2,1172,1321,9291,8831,7091,779
Property, Plant & Equipment
1,2131,2241,2491,2551,141874.59
Long-Term Investments
76.8671.2180.7181.0846.66-
Goodwill
23.123.1----
Other Intangible Assets
202.06207.0135.634.4634.6133.71
Long-Term Deferred Tax Assets
25.4823.6811.58.578.7312.16
Long-Term Deferred Charges
101.0799.1777.5154.9245.3612.35
Other Long-Term Assets
18.9317.3416.7329.8932.0963.39
Total Assets
3,7773,7983,4003,3473,0182,775
Accounts Payable
105.03124.98144.35180.94156.86203.92
Accrued Expenses
26.2449.41266.85218.97190.72156.1
Short-Term Debt
45.38110.7174.44180.95105.2920.02
Current Portion of Long-Term Debt
4.44.43.672.93--
Current Income Taxes Payable
29.3730.584.623.341.462.71
Current Unearned Revenue
27.8923.3138.2831.9828.7110.99
Other Current Liabilities
315.34275.3164.1241.9846.3538.72
Total Current Liabilities
553.64618.7596.32661.09529.39432.46
Long-Term Debt
31.5631.5335.9339.6--
Long-Term Unearned Revenue
60.8362.4968.2541.1842.8151.03
Long-Term Deferred Tax Liabilities
45.4746.191.71.460.880.12
Total Liabilities
691.49758.9702.21743.33573.08483.6
Common Stock
176.53176.53176.53120.09120.09120.09
Additional Paid-In Capital
1,4071,4041,3881,4441,4441,444
Retained Earnings
1,4701,4191,2081,040880.3727.45
Treasury Stock
-67.67-67.67-76.22-1.59--
Comprehensive Income & Other
1.741.261.020.990.020.07
Total Common Equity
2,9872,9332,6982,6032,4442,292
Minority Interest
98.59106.14----
Shareholders' Equity
3,0863,0392,6982,6032,4442,292
Total Liabilities & Equity
3,7773,7983,4003,3473,0182,775
Total Debt
81.33146.65114.04223.48105.2920.02
Net Cash (Debt)
1,5401,4671,3101,3001,2421,485
Net Cash Growth
14.09%11.99%0.78%4.63%-16.33%-6.35%
Net Cash Per Share
8.888.427.487.347.038.43
Filing Date Shares Outstanding
175.28168.69174.08174.93176.53176.53
Total Common Shares Outstanding
175.28168.69174.08176.49176.53176.53
Working Capital
1,5641,5131,3321,2221,1801,347
Book Value Per Share
17.0417.3915.5014.7513.8512.98
Tangible Book Value
2,7622,7032,6622,5692,4102,258
Tangible Book Value Per Share
15.7616.0215.2914.5613.6512.79
Buildings
--775.81724.27487.54152.45
Machinery
--678.03661.8673.35279.81
Construction In Progress
--189.56186.26231.12637.88
Source: S&P Global Market Intelligence. Standard template. Financial Sources.